Rare Disease and Orphan Drugs Education Center

Orphan disease companies can rely on our dedicated experience to advance a rare disease drug program through critical milestones. Browse our resources to gain new insights for your orphan drug development strategy.

Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient Survey